Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023

Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its...

Related Keywords

United States ,Boston ,Massachusetts ,Canada ,Canadian ,Mark Anderson ,Gavin Cloherty ,Sam Galhenage ,Marie Louise Vachon ,Magdy Elkhashab ,Krasimir Antonov ,Arpita Mondal ,Chao Wei Hsu ,Varun Sharma ,Calvin Chan ,Scott Davison ,Karen Sims ,Robert Bailey ,Stuartk Roberts ,Christine Espiritu ,Chi Yi Chen ,Timothy Eley ,Scott Fung ,Stuart Roberts ,Catherine Vincent ,Seyma Ozturk ,Jacob George ,Deepa Patel ,Radoslava Tsrancheva ,Susanne Obrien ,Deana Antoniello ,Andrea Cuconati ,Jieming Liu ,Troyo Harasym ,Fei Chen ,Andrew Cole ,Holly Micolochick Steuer ,N Acetylgalactosamine Galnac ,Lisam Caperelli ,Mariana Radicheva ,Nagraj Mani ,Karend Sims ,Tom Evans ,Rene Rijnbrand ,Kosh Agarwal ,Sharie Ganchua ,Christina Iott ,Gaston Picchio ,Gail Matthews ,Luisam Stamm ,Elina Medvedeva ,Amanda Pohl ,Curtis Cooper ,Stevenj Knox ,Fung Yuen ,Zina Valaydon ,Louise Bussey ,Michele Anderson ,Katie Zomorodi ,Tiffany Fortney ,Amych Lee ,Rozalina Balabanska ,Fran Xu ,Tilly Varughese ,Gerry Macquillan ,Gavin Heffernan ,Andrzej Ardzinski ,World Health Organization ,Securities Exchange ,Arbutus Biopharma Corporation Nasdaq ,Biopharma Corporation ,American Association ,Liver Diseases ,Breaking Abstract Acceptance ,Preliminary Pharmacodynamics ,Repeat Dosing ,Non Cirrhotic Subjects ,Wan Long Chuang ,Sheng Shun Yang ,Emily Thi ,Susanneo Brien ,Abstract Acceptances ,Baseline Nucleotide Polymorphisms Within ,Poster Hall ,Oral Small Molecule Liver Tropic ,Emilyp Thi ,Ingrid Graves ,Kristiy Fan ,Angelam Lam ,New Therapies ,Tran Yan ,Grace Wang ,Securities Act ,Securities Exchange Act ,Arbutu Annual Report ,Arbutu Quarterly Reports ,Markets ,